Clinical Trial Update: IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes sequential IOMAB-CAR-T followed by CAR-T cell therapy for relapsed/refractory diffuse large B-cell lymphoma and other Non-H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CAR-T cell therapy
• IOMAB-CAR-T

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING